EN - Anglická CZ - Česká SK - Slovenská PL - Polská RO - Rumunská RU - Ruská TR - Turecká UA - Ukrajinská
EN - Anglická
  • CZ - Česká
  • SK - Slovenská
  • PL - Polská
  • RO - Rumunská
  • RU - Ruská
  • TR - Turecká
  • UA - Ukrajinská

BIOSUIS PARVOERY SUSPENSION FOR INJECTION FOR PIGS

Homepage Products Veterinary products BIOSUIS PARVOERY SUSPENSION FOR INJECTION FOR PIGS

For active immunisation of pigs (gilts, sows) to reduce clinical signs (skin lesions and fever) of swine erysipelas caused by Erysipelothrix rhusiopathiae and to prevent transplacental infection of embryos and foetuses of gilts and sows caused by porcine parvovirus.

type of preparative: Vaccines
target species animals: Pig

Can we help you?

STATEMENT OF ACTIVE AND OTHER SUBSTANCES

Each dose (2 ml) contains:

Active substances:

Parvovirus suis, inactivatum, strain CAPM V198, S-27                       ≥ 4 log2 *)

Erysipelothrix rhusiopathiae, inactivated, serotype 2, strain 2‑64       RP ³ 1 **)


*) The titre of HI antibodies in the guinea pig serum after administration of ¼ of the vaccine dose. An antibody titre of 16 and over must be demonstrated in 4 of 5 guinea pigs. The resulting HI titre is determined as the mean of antibody titres achieved in 5 guinea pigs.

**) Relative potency (RP) is determined by comparing the antibody level with the antibody level in the serum prepared with a reference batch of the vaccine that passed the challenge test on target animals according to the Ph.Eur. monograph as amended.


Adjuvant:      

Aluminium hydroxide***)      9.0 mg


***)  hydrated, for adsorption 2% (expressed as Al2O3)   


Excipients:     

Formaldehyde                max. 1.0 mg

Thiomersal                              0.2 mg


Suspension for injection.

Milky white to off-white liquid. During prolonged standing, the content is divided into a clear liquid and a milky white to off-white sediment.


INDICATIONS

 

For active immunisation of pigs (gilts, sows) to reduce clinical signs (skin lesions and fever) of swine erysipelas caused by Erysipelothrix rhusiopathiae and to prevent transplacental infection of embryos and foetuses of gilts and sows caused by porcine parvovirus. 


Onset of immunity:

Porcine parvovirus:       3 weeks after basic vaccination (from the beginning of                                    pregnancy)

E. rhusiopathiae:           3 weeks after basic vaccination.


Duration of immunity:

Porcine parvovirus:                 Vaccination provides foetal protection throughout                                            pregnancy.

E. rhusiopathiae:                     6 months after basic vaccination


CONTRAINDICATIONS

None.


ADVERSE REACTIONS

The application may very often result in a transient slight temperature increase by not more than 0.9°C, which lasts for 4 days as a maximum.

The reddening of the skin may appear sporadically around the site of vaccination, which disappears usually within two to four days after vaccination.

Swelling about 2-3 cm in diameter may occur rarely around the injection site, which disappears usually 2 to 6 days after administration.

Vaccination may very rarely cause a hypersensitivity reaction in animals sensitive to erysipelas infection.


The frequency of adverse reactions is characterised according to the following rules:

very common (adverse reactions occurred in more than 1 in 10 treated animals)

common (more than 1 but less than 10 in 100 treated animals)

uncommon (more than 1 but less than 10 in 1,000 treated animals)

rare (more than 1 but less than 10 in 10,000 treated animals)

very rare (less than 1 in 10,000 treated animals, including isolated reports).


If you notice any serious effects or other effects not mentioned in this leaflet, or if you think that the drug has no effect, please inform your veterinary surgeon.

Alternatively you can report via your national reporting system (www.uskvbl.cz).


TARGET SPECIES

Pigs (gilts, sows).


DOSAGE FOR EACH SPECIES, ROUTE AND METHOD OF ADMINISTRATION

Vaccine dose - always 2 ml intramuscularly into the neck muscle behind the ear.


Gilts:

Basic vaccination - from 6 months of age 2 vaccine doses, 6 weeks and 3 weeks prior to mating. In the case of previous vaccination against parvovirus and swine erysipelas with Bioveta’s vaccines, if available (one dose of erysipelas vaccine from 8 weeks of age and one dose of parvovirus vaccine 6 weeks before mating), one vaccine dose administered 3 weeks before mating will do.

Further regular revaccinations with one vaccine dose not later than 3 weeks before each mating (but not later than 6 months after the previous vaccination).

Sows:

Basic vaccination - in the case of previous vaccination against parvovirus and erysipelas with Bioveta’s vaccines (see the vaccination schedule for gilts), one vaccine dose administered 3 weeks before mating will do.

If the sows have not been vaccinated as gilts (before the first farrowing), basic vaccination must be carried out as in gilts.

Further regular revaccinations with one vaccine dose not later than 3 weeks before each mating (but not later than 6 months after the previous vaccination).


ADVICE ON CORRECT ADMINISTRATION

It is recommended to heat the vaccine to room temperature and shake the vial prior to use (shake the 250 ml pack also during application). Use a sterile injection material, free of antiseptic and/or disinfectant agents.

Observe usual aseptic conditions.

Do not use BIOSUIS ParvoEry suspension for injection if you notice visible signs of deterioration of the primary packaging.


WITHDRAWAL PERIODS

Not applicable.


SPECIAL STORAGE PRECAUTIONS

Keep out of the sight and reach of children.

Store and transport refrigerated (2 °C – 8 °C).

Protect from frost.

Protect from light.

Do not use this veterinary medicinal product after the expiry date which is stated on the label.

Shelf life after first opening the immediate packaging: 10 hours.


SPECIAL WARNINGS

Special warnings for each target species:

Vaccinate healthy animals only.


Special precautions for use in animals:

Not applicable.


Special precautions to be taken by the person administering the veterinary medicinal product to animals:

In case of accidental self-injection seek medical advice immediately and show the package leaflet or label to a practitioner.


Pregnancy:

Do not use during pregnancy.


Lactation:

The product can be used during lactation.


Incompatibilities:

Do not mix with other veterinary medicinal products.


Overdose (symptoms, emergency procedures, antidotes):

Not applicable.


Interaction with other medicinal products and other forms of interaction:

No information is available on the safety and efficacy of this vaccine when administered with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be decided on a case by case basis.


SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIALS, IF ANY

Medicines should not be disposed of via wastewater or household waste.

Ask your veterinary surgeon how to dispose of medicines no longer required. These measures should help to protect the environment.


OTHER INFORMATION

Pack size:

Paper box: 1 x 10 ml, 1 x 50 ml, 1 x 100 ml, 1 x 250 ml

Plastic box: 10 x 10 ml

Not all pack sizes may be marketed.


For animal treatment only.

Veterinary medicinal product subject to prescription.


Contact us


antispam
Please fill in the text displayed in the picture

or call


+420 517 318 598